Predictive Platforms of Bond Cleavage and Drug Release Kinetics for Macromolecule-Drug Conjugates.

antibody–drug conjugates bond cleavage kinetics drug release kinetics linkers macromolecules pharmacokinetics polymer–drug conjugates

Journal

Annual review of chemical and biomolecular engineering
ISSN: 1947-5446
Titre abrégé: Annu Rev Chem Biomol Eng
Pays: United States
ID NLM: 101574034

Informations de publication

Date de publication:
07 06 2021
Historique:
pubmed: 18 3 2021
medline: 26 10 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

Macromolecule-drug conjugates (MDCs) occupy a critical niche in modern pharmaceuticals that deals with the assembly and combination of a macromolecular carrier, a drug cargo, and a linker toward the creation of effective therapeutics. Macromolecular carriers such as synthetic biocompatible polymers and proteins are often exploited for their inherent ability to improve drug circulation, prevent off-target drug cytotoxicity, and widen the therapeutic index of drugs. One of the most significant challenges in MDC design involves tuning their drug release kinetics to achieve high spatiotemporal precision. This level of control requires a thorough qualitative and quantitative understanding of the bond cleavage event. In this review, we highlight specific research findings that emphasize the importance of establishing a precise structure-function relationship for MDCs that can be used to predict their bond cleavage and drug release kinetic parameters.

Identifiants

pubmed: 33730514
doi: 10.1146/annurev-chembioeng-091720-030636
doi:

Substances chimiques

Drug Carriers 0
Pharmaceutical Preparations 0
Polymers 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-261

Auteurs

Souvik Ghosal (S)

Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14850, USA; email: caa238@cornell.edu.

Javon E Walker (JE)

Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14850, USA.

Christopher A Alabi (CA)

Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14850, USA; email: caa238@cornell.edu.
Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14850, USA.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Animals Huntington Disease Mitochondria Neurons Mice

Classifications MeSH